ForeverLabs
ServicesProvidersScienceMissionSupport
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Adipose Derived Mesenchymal Stromal Cells
 Southern Surgical Arts in Chattanooga (TN)
Blog
Apr 6, 2026
1 min read
Forever Labs and Southern Surgical Arts Partner to Reshape the Future of Longevity
Adipose Derived Mesenchymal Stromal CellsAdipose Derived Stem Cells
PJetYCLWQHZMfaL8D1jRK.png
Clinical
Nov 27, 2025
1 min read
Web
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human
Authors: M. Mashayekhi et al. (published Jan 6, 2021)
Premature Ovarian FailureIntra Ovarian TransplantationWomen's HealthAdipose Derived Mesenchymal Stromal Cells

Stay in touch

Shop

Annual planLifetime planClient LoginScheduler Login

Learn

ArticlesBlogPodcastFAQISO 9001:2015ISO Accredited

Careers

About usPrivacy policyPressTerms of Use

Questions

Clinics & LocationsFor physiciansPartner with usCareersContact us(888) 732-2375
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTubeLinktree

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.